This, together with the fact that CDCP1 showed no negative correlation to the degree of fibrosis but rather to NAFLD Activity Score (NAS) as a measurement of disease activity (data not shown), suggested that CDCP1 levels instead associated with active liver inflammation. The gene discussed is CDCP1; the disease is metabolic dysfunction-associated steatotic liver disease.